Raseglurant
id:
raseglurant-180-3358530
title:
Raseglurant
text:
Raseglurant (INN) is a negative allosteric modulator of the mGlu5 receptor and derivative of MPEP which was under development by Addex Therapeutics for the treatment of migraine, gastroesophageal reflux disease, and dental anxiety. It reached phase II clinical trials for all of the aforementioned indications before being discontinued due to the observation of possible predictive signs of hepatotoxicity in patients with long-term use.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Raseglurant
date created:
2014-12-28T09:10:43Z
date modified:
2024-09-05T09:10:40Z
main entity:
{"identifier":"Q21098859","url":"https://www.wikidata.org/entity/Q21098859"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c1/Raseglurant.svg","width":1160,"height":960}
fields total:
13
integrity:
16